Chinese medicine Tongxinluo increases tight junction protein levels by inducing KLF5 expression in microvascular endothelial cells

Tongxinluo (TXL) is a compound prescription formulated according to the meridian theory of traditional Chinese medicine. It may play an important role in cardiovascular protection by improving endothelial cell function. The aim of present study was to investigate whether endothelial protection with TXL is related to its regulation of tight junction protein expression. Human cardiac microvascular endothelial cells (HCMECs) were cultured and treated with 10−7 mol l−1 angiotensin II (Ang II) and the different doses of TXL; the expression of tight junction proteins occludin, claudin, VE‐cadherin and beta‐catenin was determined by Western blotting and real‐time PCR. Gain‐of‐function and loss‐of‐function of Krüppel‐like factor 5 (KLF5) were carried out in HCMEC transfected with either KLF5 adenovirus pAd‐KLF5 or siRNA specific for KLF5. Angiotensinogen transgenic mice were treated with TXL by oral administration of TXL of 0.75 g kg−1 day−1, and immunohistochemical staining was performed with antioccludin, anticlaudin, anti‐VE‐cadherin, antibeta‐catenin and anti‐KLF5 antibodies. Ang II treatment significantly reduced the expression of tight junction proteins occludin, claudin, VE‐cadherin and beta‐catenin in cultured HCMECs. TXL pretreatment could abrogate the down‐regulation of these tight junction proteins induced by Ang II. Ang II treatment also decreased KLF5 expression at the mRNA and protein levels; TXL pretreatment markedly reversed the inhibitory effect of Ang II on KLF5 expression. Gain‐of‐function and loss‐of‐function of KLF5 showed that KLF5 mediated the expression of tight junction proteins in HCMECs. TXL‐enhanced expression of the tight junction proteins was mediated by KLF5. In angiotensinogen transgenic mice, TXL also increased the tight junction protein levels by inducing KLF5 expression. Chinese medicine TXL increases tight junction protein levels by inducing KLF5 expression in microvascular endothelial cells. Copyright © 2015 John Wiley & Sons, Ltd.

[1]  Ruonan Zhang,et al.  Tongxinluo inhibits vascular inflammation and neointimal hyperplasia through blockade of the positive feedback loop between miR-155 and TNF-α. , 2014, American journal of physiology. Heart and circulatory physiology.

[2]  Q. Yang,et al.  Tongxinluo Protects against Pressure Overload–Induced Heart Failure in Mice Involving VEGF/Akt/eNOS Pathway Activation , 2014, PloS one.

[3]  Anna L. Brown,et al.  The double life of KLF5: Opposing roles in regulation of gene‐expression, cellular function, and transformation , 2013, IUBMB life.

[4]  S. de Bentzmann,et al.  Disruption of the Endothelial Barrier by Proteases from the Bacterial Pathogen Pseudomonas aeruginosa: Implication of Matrilysis and Receptor Cleavage , 2013, PloS one.

[5]  X. Dai,et al.  Proinflammatory Stimuli Engage Brahma Related Gene 1 and Brahma in Endothelial Injury , 2013, Circulation research.

[6]  M. Daemen,et al.  Biomechanical factors as triggers of vascular growth. , 2013, Cardiovascular Research.

[7]  Jian rong Liu,et al.  The protective role of Tongxinluo on blood-brain barrier after ischemia-reperfusion brain injury. , 2013, Journal of ethnopharmacology.

[8]  Bin Zheng,et al.  Localization and function of KLF4 in cytoplasm of vascular smooth muscle cell. , 2013, Biochemical and biophysical research communications.

[9]  E. Maggioli,et al.  Identification of an essential endogenous regulator of blood–brain barrier integrity, and its pathological and therapeutic implications , 2012, Proceedings of the National Academy of Sciences.

[10]  K. Fujiu,et al.  Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. , 2011, The Journal of clinical investigation.

[11]  Kun Wu,et al.  Chinese medicine Tongxinluo modulates vascular endothelial function by inducing eNOS expression via the PI-3K/Akt/HIF-dependent signaling pathway. , 2011, Journal of ethnopharmacology.

[12]  Mei Han,et al.  ATRA activates and PDGF‐BB represses the SM22α promoter through KLF4 binding to or dissociating from its cis‐DNA elements , 2011, Cardiovascular research.

[13]  Yihai Cao,et al.  Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells , 2010, Proceedings of the National Academy of Sciences.

[14]  H. Gavras,et al.  Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant. , 2009, American journal of hypertension.

[15]  C. Zhang,et al.  Chinese medicine tongxinluo significantly lowers serum lipid levels and stabilizes vulnerable plaques in a rabbit model. , 2009, Journal of ethnopharmacology.

[16]  Yuejin Yang,et al.  Pretreatment with Tongxinluo protects porcine myocardium from ischaemia/reperfusion injury through a nitric oxide related mechanism. , 2009, Chinese medical journal.

[17]  K. Zhao,et al.  Acetylation of KLF5 Alters the Assembly of p15 Transcription Factors in Transforming Growth Factor-β-mediated Induction in Epithelial Cells* , 2009, The Journal of Biological Chemistry.

[18]  Toru Suzuki,et al.  Krüppel-like Factor 5 Shows Proliferation-specific Roles in Vascular Remodeling, Direct Stimulation of Cell Growth, and Inhibition of Apoptosis* , 2009, Journal of Biological Chemistry.

[19]  L. Janssen,et al.  Cardiovascular and airway relaxant activities of peony root extract. , 2008, Canadian journal of physiology and pharmacology.

[20]  F. Rossi,et al.  Ghrelin inhibits angiotensin II-induced migration of human aortic endothelial cells. , 2007, Atherosclerosis.

[21]  K. Fujiu,et al.  Synthetic Retinoid Am80 Suppresses Smooth Muscle Phenotypic Modulation and In-Stent Neointima Formation by Inhibiting KLF5 , 2005, Circulation research.

[22]  A. Lumsden,et al.  Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. , 2005, Journal of vascular surgery.

[23]  H. Nishimatsu,et al.  Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling , 2002, Nature Medicine.

[24]  Wu Yl,et al.  Clinical study on tongxinluo capsule in treatment of patients with angina pectoris caused by coronary heart disease , 1997 .

[25]  G. Palade,et al.  JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA , 1963, The Journal of cell biology.

[26]  J. Zeng,et al.  Tongxinluo attenuates neuronal loss and enhances neurogenesis and angiogenesis in the ipsilateral thalamus and improves neurological outcome after focal cortical infarction in hypertensive rats. , 2014, Restorative neurology and neuroscience.

[27]  Mei Han,et al.  Krüppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs , 2010, Acta Pharmacologica Sinica.

[28]  Yun Zhang,et al.  vulnerable plaques: A comparison with a high-dose simvastatin therapy , 2009 .

[29]  R. Gao,et al.  [Clinical study on tongxinluo capsule in treatment of patients with angina pectoris caused by coronary heart disease]. , 1997, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.